MEDICLIN's First Half 2025 Interim Results Show Growth

MEDICLIN AG has reported positive interim financial results for the first half of 2025, highlighting significant growth. The group achieved consolidated sales of EUR 383.8 million, a 4.3% increase from the previous year. The operating result doubled to EUR 22.4 million compared to EUR 11.9 million in the first half of 2024. The group's capacity utilization remained stable at 86.1%.

The Post-Acute segment experienced a 10.2% rise in sales, reaching EUR 257.0 million. In contrast, the Acute segment saw a decline in sales due to the sale of the MEDICLIN Herzzentrum Coswig, but operating results improved. Sales in the Care and Service segments showed growth, with Service seeing a notable increase in its operating result.

The outlook for the fiscal year remains optimistic with anticipated sales growth of 2.0% to 5.0% and an operating profit forecast between EUR 53.0 million and EUR 64.0 million.